Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Acid ceramidase expression modulates the sensitivity of A375 melanoma cells to dacarbazine.

Bedia C, Casas J, Andrieu-Abadie N, Fabriàs G, Levade T.

J Biol Chem. 2011 Aug 12;286(32):28200-9. doi: 10.1074/jbc.M110.216382. Epub 2011 Jun 23.

2.

Anti-melanoma activity of the 9.2.27PE immunotoxin in dacarbazine resistant cells.

Risberg K, Fodstad O, Andersson Y.

J Immunother. 2010 Apr;33(3):272-8. doi: 10.1097/CJI.0b013e3181c54991.

PMID:
20445347
3.

O6-methylguanine-DNA-methyltransferase expression and gene polymorphisms in relation to chemotherapeutic response in metastatic melanoma.

Ma S, Egyházi S, Ueno T, Lindholm C, Kreklau EL, Stierner U, Ringborg U, Hansson J.

Br J Cancer. 2003 Oct 20;89(8):1517-23.

4.
5.

Analysis of O(6)-methylguanine-DNA methyltransferase in melanoma tumours in patients treated with dacarbazine-based chemotherapy.

Ma S, Egyházi S, Martenhed G, Ringborg U, Hansson J.

Melanoma Res. 2002 Aug;12(4):335-42.

PMID:
12170182
6.

Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.

Serrone L, Zeuli M, Sega FM, Cognetti F.

J Exp Clin Cancer Res. 2000 Mar;19(1):21-34.

PMID:
10840932
7.

Increased acid ceramidase expression depends on upregulation of androgen-dependent deubiquitinases, USP2, in a human prostate cancer cell line, LNCaP.

Mizutani N, Inoue M, Omori Y, Ito H, Tamiya-Koizumi K, Takagi A, Kojima T, Nakamura M, Iwaki S, Nakatochi M, Suzuki M, Nozawa Y, Murate T.

J Biochem. 2015 Oct;158(4):309-19. doi: 10.1093/jb/mvv039. Epub 2015 Apr 17.

PMID:
25888580
8.

Combined treatment with Ad-hTRAIL and DTIC or SAHA is associated with increased mitochondrial-mediated apoptosis in human melanoma cell lines.

Lillehammer T, Engesaeter BO, Prasmickaite L, Maelandsmo GM, Fodstad O, Engebraaten O.

J Gene Med. 2007 Jun;9(6):440-51.

PMID:
17410615
9.

[Hypersensitivity to dacarbazine in patients with metastatic malignant melanoma].

Levy A, Guitera P, Kerob D, Ollivaud L, Archimbaud A, Dubertret L, Basset-Seguin N.

Ann Dermatol Venereol. 2006 Feb;133(2):157-60. French.

PMID:
16508601
10.

Anti-DR5 monoclonal antibody-mediated DTIC-loaded nanoparticles combining chemotherapy and immunotherapy for malignant melanoma: target formulation development and in vitro anticancer activity.

Ding B, Wu X, Fan W, Wu Z, Gao J, Zhang W, Ma L, Xiang W, Zhu Q, Liu J, Ding X, Gao S.

Int J Nanomedicine. 2011;6:1991-2005. doi: 10.2147/IJN.S24094. Epub 2011 Sep 15.

11.

Influence of therapy on the antioxidant status in patients with melanoma.

Gadjeva V, Dimov A, Georgieva N.

J Clin Pharm Ther. 2008 Apr;33(2):179-85. doi: 10.1111/j.1365-2710.2008.00909.x.

PMID:
18315784
12.

Targeting nodal in conjunction with dacarbazine induces synergistic anticancer effects in metastatic melanoma.

Hardy KM, Strizzi L, Margaryan NV, Gupta K, Murphy GF, Scolyer RA, Hendrix MJ.

Mol Cancer Res. 2015 Apr;13(4):670-80. doi: 10.1158/1541-7786.MCR-14-0077. Epub 2015 Mar 12.

13.

Genistein stimulates MCF-7 breast cancer cell growth by inducing acid ceramidase (ASAH1) gene expression.

Lucki NC, Sewer MB.

J Biol Chem. 2011 Jun 3;286(22):19399-409. doi: 10.1074/jbc.M110.195826. Epub 2011 Apr 14.

14.

Gallic acid inhibits the migration and invasion of A375.S2 human melanoma cells through the inhibition of matrix metalloproteinase-2 and Ras.

Lo C, Lai TY, Yang JS, Yang JH, Ma YS, Weng SW, Lin HY, Chen HY, Lin JG, Chung JG.

Melanoma Res. 2011 Aug;21(4):267-73. doi: 10.1097/CMR.0b013e3283414444.

PMID:
21734530
15.

B16 and cloudman S91 mouse melanoma cells susceptibility to apoptosis after dacarbazine treatment.

Olszewska-Słonina DM, Styczyńisk J, Drewa TA, Olszewski KJ, Czajkowski R.

Acta Pol Pharm. 2005 Nov-Dec;62(6):473-83.

16.

Bcl-2 overexpression prevents apoptosis induced by ceramidase inhibitors in malignant melanoma and HaCaT keratinocytes.

Raisova M, Goltz G, Bektas M, Bielawska A, Riebeling C, Hossini AM, Eberle J, Hannun YA, Orfanos CE, Geilen CC.

FEBS Lett. 2002 Apr 10;516(1-3):47-52.

17.

Exposure of melanoma cells to dacarbazine results in enhanced tumor growth and metastasis in vivo.

Lev DC, Onn A, Melinkova VO, Miller C, Stone V, Ruiz M, McGary EC, Ananthaswamy HN, Price JE, Bar-Eli M.

J Clin Oncol. 2004 Jun 1;22(11):2092-100. Epub 2004 May 3.

PMID:
15123733
18.
19.

Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune response.

Wack C, Kirst A, Becker JC, Lutz WK, Bröcker EB, Fischer WH.

Cancer Immunol Immunother. 2002 Oct;51(8):431-9. Epub 2002 Jul 25.

PMID:
12202904

Supplemental Content

Support Center